[CNDSN7 March 14 news (reporter Shen Jie) 1994 may, to Zhejiang Conba Pharmaceutical Co., Ltd. for main member companies of Conba group set up in Hangzhou, the scope of business includes investment and industrial operation, involved in the industry, covering many fields. At present, it has formed the pharmaceutical industry to industry, biological industry of agriculture, health food and beverage industry, supplemented by the industrial system. Conba always adhere to build the core competitiveness of enterprises, brand development and has been the two major weapon Conba development. In 2015 June 5, Ministry of Commerce issued Conba officially licensed news, which means Conba eventually to the tree brand, a cause of success on the road.

Quality research, to create a health industry professional brand

Quality is the life of an enterprise, therefore Conba pay special attention to the cultivation and protection of corporate brand and product brand, in multiple areas of urinary system and cardio cerebral vascular system created a consumer be known and recognized brand. Now, Conba has become one of the most famous trademarks and brand names of the enterprises of Zhejiang province have. Among them, and "QianLieKang" as the company's leading products of plant medicine, has become the first brand of domestic traditional Chinese medicine in the treatment of benign prostatic hyperplasia; "Taponin" is China's first in line with international quality standards, the modern herbal medicine preparation. In addition, ale "Yan", "Tao Xi", "state", "babe", "golden Aokang" are in their respective fields have a higher brand awareness, in competing products has set up a more prominent brand advantage.

While the brand has a number of advantages come from Conba R & D technology platform and an elite technical team, to establish a long-term strategic partnership and strategic alliances with domestic and foreign well-known research institutions, tertiary institutions, in drug development, and plant extraction and structure transformation, new drug delivery systems and many other applications, research and development new drugs with independent intellectual property rights, in all aspects of medicinal plant, raw materials and plant extraction, drug development, production, marketing, has established a standardized and efficient industrial system, Zhejiang province has become the only Chinese medicine industry in national technology center, national post doctoral research workstation, academician workstation, the national innovation and enterprise Zhejiang provincial key enterprise institute in an enterprise. Under the premise of scientific research and brand double harvest, Conba actively build plants the health of the whole industry chain, industrialized seedling culture workshop, is planting and breeding workshop, plant processing processing workshop, plant extraction, separation and purification of six workshop workshop, consumer goods production workshop, brand management and service workshop, for consumers to comprehensively build a safe, green barrier.

With the Internet industry, Zaizhuhuihuang Conba

Since the beginning of this year, with China set off a shares overwhelming "Internet + movement, Conba continue to implementation of" endogenous + extension "two wheeled driven strategy, around the integration and the Internet of center of gravity, on the one hand to promote the integration of internal resources, actively docking external resources, and constantly improve the management quality, to do bigger and stronger the stock business; on the one hand, intensify support new ecology, develop new energy, and actively promote the Internet business model innovation based on. Especially in the first half of the year, company holding Jane Cheng pharmaceutical online stock company, vigorously develop the internet pharmaceutical business; at the same time, and actively increase on the acquisition of subsidiaries and the remaining equity control, complete 100% holding in Guizhou Baite and ZSM pharmaceutical, and holdings of Jiangxi tianshikang shares; in addition, the company also invested in the Jiaxing Yikang Biological Technology Co., Ltd., started the layout of in vitro diagnostic reagent industry. All of these are for Conba "Twelfth Five Year Plan" of the successful ending, and 45 "the rapid development of the foundation, the power savings.

Also Conba Chairman Hu Jiqiang in the next step pointed out that Conba to in accordance with the requirements of two docking, do two aspects of work. The first to continue to make full use of the capital market, increase the intensity of mergers and acquisitions. Conba proposed a goal, through the integration of domestic and international traditional medicine and modern herbal medicine resources, to create the first stage of the world traditional medicine and modern herbal medicine, through the consolidation and merger; the second is to docking technology. First of all, Conba pharmaceutical industry has started the internet. Through the docking of the Internet technology, the now sell drugs occurred fundamental changes, the products in the future can be directly through the B2B direct reach retail terminal, without going through the primary, secondary and tertiary level wholesale. Also through the B2C, can be directly to consumers online orders, direct distribution, that is, through the B2B retail terminal o2o sales, so a docking to promote Conba throughout the pharmaceutical industry of the Internet. Second, but also through the capital, to meet the international most advanced drug innovation platform for docking, which makes Conba can jump to a innovation to promote the development of such a platform, so a seize the world bio pharmaceutical innovation and the development of such a chance!

Finally in February 8, 2015, the 30 anniversary celebration in Conba, chairman Hu Jiqiang said the company's future direction. "2015 is Conba Internet first year, enterprises will be fully realized the Internet, in the next 30 years to rebuild a Conba."